Pro B-type natriuretic peptide stongly predicts all cause and cardiovascular mortality in peripheral arterial disease patients with as well as in those without type 2 diabetes

被引：0
|
作者：
Zanolin, Daniela [1 ]
Rein, Philipp [1 ,2 ]
Saely, Christoph [1 ,2 ,3 ]
Vonbank, Alexander [1 ,2 ]
Lins, Christina [1 ]
Leiherer, Andreas [1 ,3 ]
Muendlein, Axel [1 ]
Schuler, Alexandra [1 ,2 ]
Ebner, Karl-Martin [1 ,2 ]
Schwerzler, Peter [1 ,2 ]
Mader, Arthur [1 ,2 ]
Drexel, Heinz [1 ,3 ,4 ]
机构：
[1] VIVIT Inst, Feldkirch, Austria
[2] Acad Teaching Hosp, Feldkirch, Austria
[3] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[4] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2017年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P21
引用
收藏
页码：S127 / S127
页数：1
相关论文
共 50 条
  • [31] Association of handgrip strength with B-type natriuretic peptide levels and cardiovascular events in patients with type 2 diabetes
    Hamasaki, H.
    DIABETES & METABOLISM, 2019, 45 (02) : 209 - 211
  • [32] Pro-B-type natriuretic peptide predicts mortality in critically ill patients
    B Meyer
    M Huelsmann
    GDelle Karth
    P Wexberg
    O Wagner
    G Heinz
    Critical Care, 9 (Suppl 1):
  • [33] B-Type Natriuretic Peptide and Long-Term Cardiovascular Mortality in Patients With Coronary Heart Disease
    Stewart, Ralph A. H.
    Kirby, Adrienne
    White, Harvey D.
    Marschner, Simone L.
    West, Malcolm
    Thompson, Peter L.
    Sullivan, David
    Janus, Edward
    Hunt, David
    Kritharides, Leonard
    Keech, Anthony
    Simes, John
    Tonkin, Andrew M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (13):
  • [34] Aortic Augmentation Index is Independently Associated With N-Terminal Pro B-type Natriuretic Peptide in Patients With Peripheral Arterial Disease
    Shahin, Yousef
    Chetter, Ian
    VASCULAR AND ENDOVASCULAR SURGERY, 2012, 46 (08) : 648 - 653
  • [35] B-type natriuretic peptide and risk of type 2 diabetes mellitus
    杨敏
    China Medical Abstracts (Internal Medicine), 2016, 33 (02) : 19 - 19
  • [36] B-type natriuretic peptide and the risk of developing type 2 diabetes
    Yang, Min
    Ni, Changlin
    Chang, Baocheng
    Tang, Yunzhao
    Zhu, Yanjuan
    Li, Chenguang
    Jiang, Zhenhuan
    Yu, Ping
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 1 - 2
  • [37] THE CERAMIDE-BASED CORONARY EVENT RISK TEST (CERT) PREDICTS CARDIOVASCULAR MORTALITY IN CARDIOVASCULAR DISEASE PATIENTS WITH TYPE 2 DIABETES AS WELL AS IN THOSE WITHOUT DIABETES
    Leiherer, A.
    Muendlein, A.
    Saely, C. H.
    Laaksonen, R.
    Laaperi, M.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Baumgartner, I.
    Fraunberger, P.
    Drexel, H.
    ATHEROSCLEROSIS, 2020, 315 : E74 - E75
  • [38] Differences of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide levels in patients with cardiogenic shock
    Buerke, Michael
    Prondzinsky, Roland
    Geppert, Alexander
    Jaral, Rudolf
    Huber, Kurt
    Russ, Martin
    Lemm, Henning
    Schlitt, Axel
    Werdan, Karl
    CIRCULATION, 2007, 116 (16) : 944 - 944
  • [39] Pro-B-Type Natriuretic Peptide Strongly Predicts Future Vascular Events in Angiographied Coronary Patients With as Well as in Those Without the Metabolic Syndrome
    Rein, Philipp
    Zanolin, Daniela
    Leiherer, Andreas
    Vonbank, Alexander
    Saely, Christoph H.
    Drexel, Heinz
    DIABETES, 2016, 65 : A114 - A114
  • [40] B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are comparably useful for disease monitoring in heart failure
    Hammerer-Lercher, A
    Pölzl, G
    Falkensammer, G
    Ludwig, W
    Hügel, H
    Puschendorf, B
    Pachinger, O
    Mair, J
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 106 (03) : 415 - 417
12345